All In MedTech

Device Trial Radar · NCT05610267

Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair

A Retrospective Analysis of the Use of Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair

Last checked: Nov 20, 2026Latest source record: Jun 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

28

Actual

Start

Nov 22, 2022

Primary completion

Dec 28, 2022

Study completion Dec 28, 2022

Sponsor

Lead sponsor
Integra LifeSciences CorporationPublic (IART)
Sponsor type
Industry
First posted
Nov 9, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect additional safety data and demonstrate the performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs.

Conditions

  • Ventral Hernia

Interventions

  • Retrospective chart reviewDevice

    The retrospective chart review will include the full consecutive series of patients between 22 years and 80 years old who underwent abdominal wall reconstruction for achart hernia with Integra Gentrix® Surgical Matrix during the time period between November 1, 2017, and present (90 days prior to the start of data collection).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Post-operative Complications Requiring Procedural Intervention Within 90 Days Post Index ProcedureTime frame: 90 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Surgical Healing Arts Center

    Fort Myers, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.